Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.35 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.30 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16641283 | 0.96 | L3MBTL1 (0.43) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL16641280 | 0.96 | L3MBTL1 (0.43) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL15337987 | 0.96 | L3MBTL1 (0.43) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL22140737 | 0.96 | L3MBTL1 (0.39) | KDM4EATML3MBTL1AVPR1ATSPO | |
| SCHEMBL15337988 | 0.95 | L3MBTL1 (0.42) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL16641293 | 0.95 | L3MBTL1 (0.44) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL16641289 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL16641288 | 0.94 | L3MBTL1 (0.41) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL10001519 | 0.94 | PGR (0.35) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL16641279 | 0.94 | KDM4E (0.45) | KDM4EATML3MBTL1TSPOPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9196837-B2 | Compound having indenocarbazole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-11-24 | — | — | US | disclosed |
| US-9196837-B2 | Compound having indenocarbazole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-11-24 | — | — | US | disclosed |
| US-20130126856-A1 | COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20130126856-A1 | COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130126856-A1 | COMPOUND HAVING INDENOCARBAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLCO2B1, SLCO1B1, SLCO2A1 | KDM4E 1716/4885ATM 4800/4885L3MBTL1 2253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.